ENDRA LIFE SCIENCES INC. |
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.32 USD | -0.84% |
|
+13.11% | -84.91% |
| Mar. 28 | Transcript : ENDRA Life Sciences Inc., Q4 2023 Earnings Call, Mar 28, 2024 | |
| Mar. 28 | ENDRA Life Sciences Inc. Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
Evolution of the average Target Price on ENDRA Life Sciences Inc.
Price target over the last 5 years
History of analyst recommendation changes
5356afd6cd4a395.rh-4bsEEXfGnw72Q6QXVRlVutz5NkNTumLbQDF792QU.l1TJV7F9OcT1u9_V22rkJScXhmQb-OeD8ezhanOOoXzbLtYij3Ypu_Ktyg~ca09df59eed6c93d1574570835499942
Analysts' Consensus
Sell
Buy
Mean consensus
BUY
Number of Analysts
1
Last Close Price
0.3227
USD
Average target price
10
USD
Spread / Average Target
+2,998.85%
High Price Target
10
USD
Spread / Highest target
+2,998.85%
Low Price Target
10
USD
Spread / Lowest Target
+2,998.85%
Consensus detail
Consensus revision (last 18 months)
Analysts covering ENDRA Life Sciences Inc.
| HC Wainwright |
EPS Revisions
- Stock Market
- Equities
- NDRA Stock
- Consensus ENDRA Life Sciences Inc.